BioNJ will honor Fred Hassan, partner and managing director, Warburg Pincus, and former Chairman of the Board & CEO, Schering-Plough, as the 2017 Dr. Sol J. Barer Award for Vision, Innovation and Leadership recipient. According to BioNJ, Hassan is a globally recognized and revered biopharmaceutical leader who is widely regarded for his passion for patients, dedication to advancing healthcare and mentoring industry leaders. Hassan has successfully reinvented and led numerous New Jersey companies to new heights delivering life-altering therapies and drugs.
Named for Dr. Sol J. Barer, founder and former chairman and CEO of Celgene Corporation, the Dr. Sol J. Barer Award for Vision, Innovation and Leadership recognizes outstanding research and business leaders who have made significant contributions to the growth and prosperity of the life sciences industry in New Jersey and throughout the world.
Hassan will be recognized on February 2, at the Hilton East Brunswick, at BioNJ’s Annual Gateway Gala & Innovation Celebration, as the organization celebrates New Jersey’s vibrant life sciences community.
Also at the Gala, a keynote by patient, patient advocate and media legend Joan Lunden will be given. Lunden will speak about her personal battle with breast cancer and share a patient’s perspective on treatment, the difficulties of navigating the healthcare system, the technology that helped her and the hard decisions a patient has to make during the battle to save their life
Additionally, the Innovator Awards honoring industry leaders who have reached significant milestones and companies with a footprint in New Jersey that have received a US Food and Drug Administration approval in 2016 will also be given.Related Articles: